Altimmune Stock Piotroski F Score

ALT Stock  USD 8.25  0.07  0.86%   
This module uses fundamental data of Altimmune to approximate its Piotroski F score. Altimmune F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Altimmune. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Altimmune financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Altimmune Altman Z Score, Altimmune Correlation, Altimmune Valuation, as well as analyze Altimmune Alpha and Beta and Altimmune Hype Analysis.
For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.
  
Long Term Debt Total is likely to gain to about 2 M in 2024, despite the fact that Net Debt is likely to grow to (127.7 M). At this time, Altimmune's Research And Ddevelopement To Revenue is comparatively stable compared to the past year. Days Payables Outstanding is likely to gain to 2,104 in 2024, despite the fact that Free Cash Flow Yield is likely to grow to (0.12).
At this time, it appears that Altimmune's Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Unavailable
Current Return On Assets

Negative

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Negative

Focus
Current Quality of Earnings (accrual)

Improving

Focus
Asset Turnover Growth

Decrease

Focus
Current Ratio Change

Increase

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Increase

Focus
Change in Gross Margin

Increase

Focus

Altimmune Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Altimmune is to make sure Altimmune is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Altimmune's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Altimmune's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities21.2 M12.1 M
Way Up
Very volatile
Non Current Liabilities Total4.7 M4.4 M
Notably Up
Very volatile
Total Assets221.2 M210.6 M
Sufficiently Up
Slightly volatile
Total Current Assets220.1 M209.6 M
Sufficiently Up
Slightly volatile

Altimmune F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Altimmune's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Altimmune in a much-optimized way.

About Altimmune Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Common Stock Shares Outstanding

55.91 Million

At this time, Altimmune's Common Stock Shares Outstanding is comparatively stable compared to the past year.

Altimmune Current Valuation Drivers

We derive many important indicators used in calculating different scores of Altimmune from analyzing Altimmune's financial statements. These drivers represent accounts that assess Altimmune's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Altimmune's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap24.8M289.2M378.2M771.9M599.0M629.0M
Enterprise Value17.6M175.1M189.4M662.0M464.6M487.8M

Altimmune ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Altimmune's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Altimmune's managers, analysts, and investors.
Environmental
Governance
Social

About Altimmune Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Altimmune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Altimmune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Altimmune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Altimmune Stock Analysis

When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.